These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dose dependency and reversibility of serotonin-induced valvular heart disease in rats. Droogmans S; Roosens B; Cosyns B; Degaillier C; Hernot S; Weytjens C; Garbar C; Caveliers V; Pipeleers-Marichal M; Franken PR; Bossuyt A; Schoors D; Lahoutte T; Van Camp G Cardiovasc Toxicol; 2009 Sep; 9(3):134-41. PubMed ID: 19609730 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans. Fielden MR; Hassani M; Uppal H; Day-Lollini P; Button D; Martin RS; Garrido R; Liu X; Kolaja KL Exp Toxicol Pathol; 2010 Nov; 62(6):607-13. PubMed ID: 19781924 [TBL] [Abstract][Full Text] [Related]
12. Expression of brain and platelet serotonin transporters in sublines of rats with constitutionally altered serotonin homeostasis. Bordukalo-Niksic T; Cicin-Sain L; Jernej B Neurosci Lett; 2004 Oct; 369(1):44-9. PubMed ID: 15380305 [TBL] [Abstract][Full Text] [Related]
13. Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on serotonergic systems in neonatal rat brain regions. Aldridge JE; Meyer A; Seidler FJ; Slotkin TA Toxicol Appl Pharmacol; 2005 Mar; 203(2):132-44. PubMed ID: 15710174 [TBL] [Abstract][Full Text] [Related]
14. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature. Hendrikx M; Van Dorpe J; Flameng W; Daenen W J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020 [TBL] [Abstract][Full Text] [Related]